Brief: Titan Pharmaceuticals Gets Time To Submit Plan To Regain Nasdaq Compliance
Aug 20 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS - NASDAQ PROVIDED COMPANY WITH TIME
TO
SUBMIT A PLAN TO REGAIN COMPLIANCE WITH MINIMUM STOCKHOLDERS
EQUITY STANDARD
Source: (https://bit.ly/3hjGSti)
Further company coverage: TTNP.O
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.